Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

This study has been completed.
Information provided by:
Resistentia Pharmaceuticals AB Identifier:
First received: February 22, 2007
Last updated: August 13, 2008
Last verified: August 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)